Halozyme Therapeutics
HALO
#2325
Rank
โ‚น754.96 B
Marketcap
โ‚น6,397
Share price
-0.01%
Change (1 day)
26.68%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: โ‚น754.96 Billion

As of February 2026 Halozyme Therapeutics has a market cap of โ‚น754.96 Billion. This makes Halozyme Therapeutics the world's 2325th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น754.96 B3.84%
2025โ‚น727.03 B38.4%
2024โ‚น525.30 B29.24%
2023โ‚น406.44 B-36.16%
2022โ‚น636.64 B51.09%
2021โ‚น421.35 B-0.21%
2020โ‚น422.25 B144.28%
2019โ‚น172.85 B16.75%
2018โ‚น148.04 B-19.61%
2017โ‚น184.15 B111.82%
2016โ‚น86.93 B-41.09%
2015โ‚น147.58 B91.95%
2014โ‚น76.89 B-27.51%
2013โ‚น106.06 B156.15%
2012โ‚น41.40 B-20.62%
2011โ‚น52.16 B46.14%
2010โ‚น35.69 B42.95%
2009โ‚น24.97 B13.91%
2008โ‚น21.92 B0.85%
2007โ‚น21.73 B-11.3%
2006โ‚น24.50 B396.68%
2005โ‚น4.93 B5.26%
2004โ‚น4.68 B

End of Day market cap according to different sources

On Feb 25th, 2026 the market cap of Halozyme Therapeutics was reported to be:

โ‚น754.96 Billion
by Nasdaq info icon info icon
โ‚น754.96 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น53.725 T 7,016.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น14.005 T 1,755.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น88.254 T 11,589.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น10.451 T 1,284.33%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
โ‚น969.82 B 28.46%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚น97.72 B-87.06%๐Ÿ‡บ๐Ÿ‡ธ USA